Back to Search VC Home Page
Venture Capital Search Engine
search over 1,000 Venture Capital related sites
Keywords about VC:  

Artificial Life Ventures Inc.

1.Physical sciences venture capital portfolio companies from ARCH Venture Partners   (52%):
ARCH portfolio companies in the physical sciences are pioneering advanced solutions in communications, semiconductors, and opto-electronics. ARCH portfolio companies in the physical sciences are pioneering technology with a range of commercial applications in: Chemicals/materials Electronics/instrum...
2.Labrador Ventures   (39%):
Sean Foote Mr. Foote has been a venture capitalist investing in early stage companies for the past 8 years. He is active on the board of directors of Altierre Corporation , Eoplex Technologies , Everyone.net , ezboard , Green Border Technologies , and Integrated Materials Inc. Before venture investi...
3.Cardinal - Portfolio Companies   (37%):
Life Sciences Healthcare IT Healthcare Services Devices & Instruments Life Sciences Alnylam Cambridge, MA Drug development focused on the novel mechanism of RNA interference - IPO 5/27/04 aTyr Pharma, Inc. Biopharmaceutical Company developing novel protein biologics for regenerative medicine. Cubist...
4.Previous Investments   (33%):
Below is a partial list of the companies where the principals of CambridgeLight Partners have participated as venture investors: Adage, Inc. Graphics terminals and controllers (merged with Lexidata) Avanti Communications Corp. Open networking communications Cadec Corp. . Radio monitoring of trucks (...
5.Gunderson Dettmer, Transactions and Clients   (32%):
Investors Represented In Investment Transactions Representative Investment Banking Clients Representative Private Technology Clients Representative Public Technology Clients Representative Medical Device/Life Science Clients Venture Funds For Which The Firm Serves As General Counsel Investors Repre...
6.Beasley and Nobska Form Legenta   (32%):
FOR IMMEDIATE RELEASE Mike Beasley and Nobska Group Join to Form Legenta STEVENSON, Md., Oct 7, 2002 (BUSINESS WIRE) Michael R. "Mike" Beasley, former CEO of Icing Software, an $850 million independent business unit of IBM, and Nobska Group, a strategy consulting and merchant banking firm...
7.Commons Capital's Portfolio   (32%):
Apex Learning, Inc. , Seattle, WA Apex Learning is a leader of online instruction in K-12 education. Apex provides online courses, classroom tools and exam review materials to middle and high schools through an ASP model. Its products expand access to educational opportunities in Advanced Placement...
8.InterWest Partners - Investing in Information Technology & Life Sciences   (32%):
Information Tech Life Sciences Success Stories Life Sciences [ Biopharmaceuticals | Drug Discovery/Discovery Tools Medical Devices & Diagnostics ] Medical Devices & Diagnostics Acquired by: Acoustic Imaging Technology Corporation Acoustic Imaging Technology is a maker of diagnostic ultrasound equipm...
9.Aurora Funds   (32%):
Aurora News • 2005 • 2004 • 2003 • 2002 Portfolio Company News Newsletters Events The Aurora Funds Promotes Jan Bouten to Senior Associate Will Be Taking on a Greater Role Supporting Information Technology Opportunities for Early Stage Venture Capital Firm Research Triangle Park,...
10.Aurora Funds   (32%):
Aurora News • 2005 • 2004 • 2003 • 2002 Portfolio Company News Newsletters Events The Aurora Funds Promotes Jan Bouten to Senior Associate Will Be Taking on a Greater Role Supporting Information Technology Opportunities for Early Stage Venture Capital Firm Research Triangle Park,...
11.Fenway Partners Acquires Delimex   (30%):
Fen way Partners And Blue Capital Form Leading Provider Of Artificial Floral Products Decorative Concepts To Offer Full Range Of Products and Services NEW YORK, NY, November 24, 1997 -- Fenway Partners and Blue Capital announced the formation of Decorative Concepts, Inc. (DCI), a leading distributor...
12.BioAdvance Ventures   (30%):
BioAdvance Ventures is an innovative new venture fund formed to invest in seed and early stage life science companies, located primarily in Southeastern Pennsylvania. The fund is sponsored by BioAdvance, the Biotechnology Greenhouse Corporation of Southeastern Pennsylvania and is managed by Quaker B...
13.BioAdvance Ventures   (30%):
BioAdvance Ventures is an innovative new venture fund formed to invest in seed and early stage life science companies, located primarily in Southeastern Pennsylvania. The fund is sponsored by BioAdvance, the Biotechnology Greenhouse Corporation of Southeastern Pennsylvania and is managed by Quaker B...
14.Vanguard Ventures - Dan Eilers   (30%):
Printable Version Dan Eilers is a General Partner investing in software, hardware, storage, and other information technology companies at Vanguard. Dan brings 20 years of technology and venture capital experience to his role, including serving as the President and CEO of three companies, and the fo...
15.New Document   (29%):
Frank R. Ruderman Frank Ruderman is the Chief Executive Officer, Chairman of the Board, and a Managing Partner of Tenex Greenhouse Ventures. Additionally, Mr. Ruderman is the Chairman and CEO of Berkeley HeartLab. He is also a founder of Tenex Medical Investors, an organization of angel investors wi...
16.Aurora Funds   (28%):
Aurora News • 2005 • 2004 • 2003 • 2002 Portfolio Company News Newsletters Events The Aurora Funds Adds Jan Bouten as an Associate to the Investment Team Bouten Combines Business and Engineering Background to Identify and Support IT Investment Opportunities Research Triangle Park...
17.Venture Partners and Officers   (28%):
Our Team > Madrona Team Managing Directors Strategic Director s Venture Partners & Officers Investment Professionals "Madrona's been a great supporter of Aventail as we've developed our business over the past several years. The strategic advice and high level introductions they've made have b...
18.Easton Capital Investment Group::Transave, Inc   (27%):
Transave, Inc. Transave is a biotechnology company that treats pulmonary diseases via their proprietary inhaled lipid complexed/liposomal drug delivery technology. The Company's SLIT technology enables both sustained release and enhanced targeting of therapeutic compounds to the diseased areas of th...
19.BioAdvance, The Biotechnology Greenhouse of Southeastern Pennsylvania   (27%):
Over the next 25 years, the Commonwealth of Pennsylvania will receive an estimated $11.3 billion as part of the national settlement with the tobacco industry. All of the tobacco settlement monies received by Pennsylvania will be spent on health- and life science-related initiatives. Approximately $...
20.ARCH Venture Partners   (27%):
ARCH Managing Directors have all managed entrepreneurial operations during their careers and have played key roles in the formation and initial funding round of a wide range of companies. Steven Lazarus, Co-founder and Managing Director, Emeritus Chicago Biotechnology • Pharmaceuticals • I...

Page: 1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20  

VC Directory: A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z   Others